HYPERION DEFI, INC. Fair Value Inputs, Discount for Lack of Marketability (Deprecated 2018-01-31)
HYPERION DEFI, INC. (HYPD) reported Fair Value Inputs, Discount for Lack of Marketability (Deprecated 2018-01-31) of 40.00% for the 1-month period ending 2017-03-31, per its 10-K filed 2018-04-02.
Discontinued › Notes
us-gaap:FairValueInputsDiscountForLackOfMarketability · last filed 2018-04-02
- 2017-03-31: Fair Value Inputs, Discount for Lack of Marketability (Deprecated 2018-01-31) 1 month 40.00%.
| Period end | Fair Value Inputs, Discount for Lack of Marketability (Deprecated 2018-01-31) 1 month |
|---|---|
| 2017-03-31 | 40.00% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |